Projects per year
Personal profile
About
Federico Albrecht, M.D., is an oncologist/hematologist at Miami Cancer Institute, a part of Baptist Health South Florida. He received his medical degree from the Universidad del Salvador, in Buenos Aires, Argentina. Following graduation, he completed an internship and residency in internal medicine at the University of Miami/Jackson Memorial Hospital, where he also completed a fellowship in hematology/oncology and was the senior fellow. He is Board-certified in medical oncology.
Related documents
Education/Academic qualification
Business Administration, M.B.A., University of Miami
… → 2009
Fellowship Program - Hematology Oncology, University of Miami/Jackson Memorial Hospital
1999 → 2002
Residency Program - Internal Medicine, University of Miami/Jackson Memorial Hospital
1996 → 1999
Internship - Internal Medicine, University of Miami/Jackson Memorial Hospital
1996 → 1997
Doctor of Medicine, M.D., Universidad Del Salvador
… → 1994
External positions
Physician, Private Practice, Advanced Medical Specialties
Feb 1 2005 → Nov 1 2014
Staff Oncologist, Hospital San Bernardo
Feb 1 2003 → Dec 1 2004
Physician, Private Practice, Oncology Salta
Jan 1 2003 → Jan 1 2005
Physician, Private Practice, Oncology Hematology Group of South Florida
Jul 1 2002 → Dec 1 2002
Disciplines
- Medicine and Health Sciences
- Hematology
- Oncology
-
QUILT 2.023: A Study of N-803 in Combination With Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC.
Albrecht, F. (PI)
1/1/04 → 1/1/24
Project: Research project
-
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
Vallabhaneni, E., Kareff, S. A., Barnett, R. M., Drusbosky, L. M., Dalal, S., Raez, L. E., Santos, E. S., Albrecht, F., Cusnir, M. & Rodriguez, E., Mar 2024, In: Cancers. 16, 6, 1150.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors
Chuong, M., Mittauer, K., Tom, M., Kalman, N., McCulloch, J., Alvarez, D., Kaywin, P., Ucar, A., Albrecht, F., De Zarraga, F., Aparo, S., Rabinowits, G., Rubens, M., Gutierrez, A., Kotecha, R. & Rojas, C., May 12 2023.Research output: Contribution to conference › Presentation
-
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors
Chuong, M., Mittauer, K., Tom, M., Kalman, N., McCulloch, J., Alvarez, D., Kaywin, P., Ucar, A., Albrecht, F., De Zarraga, F., Aparo, S., Rabinowits, G., Rubens, M., Gutierrez, A., Kotecha, R. & Rojas, C., May 12 2023.Research output: Contribution to conference › Presentation
-
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors
Chuong, M., Mittauer, K., Tom, M., Kalman, N., McCulloch, J., Alvarez, D., Kaywin, P., Ucar, A., Albrecht, F., De Zarraga, F., Aparo, S., Rabinowits, G., Rubens, M., Gutierrez, A., Kotecha, R. & Rojas, C., May 12 2023.Research output: Contribution to conference › Presentation
-
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors
Chuong, M., Mittauer, K., Tom, M., Kalman, N., McCulloch, J., Alvarez, D., Kaywin, P., Ucar, A., Albrecht, F., De Zarraga, F., Aparo, S., Rabinowits, G., Rubens, M., Gutierrez, A., Kotecha, R. & Rojas, C., May 12 2023.Research output: Contribution to conference › Presentation
Activities
- 1 Other